Vivo Capital, LLC Aadi Bioscience, Inc. Transaction History

Vivo Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$11.57 - $17.92 $3.04 Million - $4.71 Million	-262,844 Reduced 34.03%	509,572 $6.28 Million
Q1 2022 May 13, 2022	SELL	$16.65 - $24.97 $8.84 Million - $13.3 Million	-530,974 Reduced 40.74%	772,416 $13.1 Million
Q4 2021 Feb 11, 2022	SELL	$19.32 - $29.02 $2.39 Million - $3.59 Million	-123,823 Reduced 8.68%	1,303,390 $31.5 Million
Q3 2021 Nov 15, 2021	BUY	$25.52 - $41.85 $36.4 Million - $59.7 Million	1,427,213 New	1,427,213 $41.9 Million

12.6M

23.8K

Ticker AADI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,016,800
Market Cap $46.7M
Description
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.